Literature DB >> 14563013

Single immunization of newborn mice with heterologous type-II collagen induces arthritic disease.

Nina Ivanovska1, Martin Yordanov, Vessela Raykovska.   

Abstract

Collagen-induced arthritis (CIA) is a widely accepted model of autoimmune disease with significant similarities to rheumatoid arthritis in humans. CIA is provoked in susceptible strains upon immunization of adult mice with native type-II collagen in complete Freund's adjuvant (CFA). Neonatal exposure to antigen is supposed to result in T cell clone deletion and induction of tolerance. Here we report that the neonatal injection of bovine type-II collagen (bCII) to ICR (CD-2) mice triggers the development of autoimmune chronic joint inflammation. Compared with standard CIA significant joint swelling was not observed and anti-collagen antibodies were not detected if the second challenge with the antigen was not supplied. Histopathologic examination of the joints showed cell infiltration, synovial hyperplasia and at the later period bone destruction. Mice immunized as neonates expressed Ag-specific proliferative response and delayed type hypersensitivity (DTH) reaction to bCII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563013     DOI: 10.1080/0891693031000116057

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

1.  Inflammation induced by inoculation of the joint with Candida albicans.

Authors:  Martin Yordanov; Svetla Danova; Nina Ivanovska
Journal:  Inflammation       Date:  2004-06       Impact factor: 4.092

2.  Developmental regulation of Foxp3 expression during ontogeny.

Authors:  Jason D Fontenot; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

Review 3.  The unique neonatal NK cells: a critical component required for neonatal autoimmune disease induction by maternal autoantibody.

Authors:  Claudia Rival; Yulius Setiady; Eileen T Samy; Jessica Harakal; Kenneth S K Tung
Journal:  Front Immunol       Date:  2014-05-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.